Generic FGFR2 Inhibitor for Cholangiocarcinoma

Futibatinib is an inhibitor made to deal with cholangiocarcinoma that has FGFR2 fusions. It works by stopping the FGFR signaling path. The tablets are 4 mg each and you’re supposed to take 20 mg once a day.

Each pack has a bottle with 28 tablets, which is a whole month’s supply for one person. This med should only be used with a healthcare provider’s help.